Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02787213 · ClinicalTrials.gov registry record

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

A clinical trial of Preterm Birth, sponsored by Sera Prognostics.

Completed
Registry status
5,011
Enrollment target
18
Study locations

NCT02787213 is a study of Preterm Birth that has completed, run by Sera Prognostics. The registered enrollment target is 5,011 participants, above the 4,494-participant average among 37 other Preterm Birth trials with a reported enrollment target (12% higher). The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02787213, a study of Preterm Birth, has completed, sponsored by Sera Prognostics.

COMPLETED
Registry status
5,011 participants
Enrollment target
18
Study locations

Study Summary

Prospective multicenter observational study to further develop and validate a preterm birth risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks gestation. A single maternal peripheral blood sample will be collected for analysis. Data related to potential risk factors for preterm birth will be obtained through maternal interview and review of medical records. Subjects will be followed through the delivery process to assess the course of pregnancy, labor, and to document any related maternal complications. Neonatal outcomes will be gathered from the medical record for up to 28 days of life or discharge, whichever occurs first.

Conditions Studied

Preterm Birth

Study Locations (18)

California

  • University of California, Irvine Medical Center - Orange
  • UC San Diego Health - San Diego

Colorado

  • University of Colorado-Denver - Aurora
  • Denver Health Medical Center - Denver

Massachusetts

  • Boston Medical Center - Boston
  • Baystate Medical Center - Springfield

North Carolina

  • University of North Carolina - Chapel Hill
  • Duke University Medical Center - Durham

South Carolina

  • Medical University of South Carolina - Charleston
  • Greenville Health System - Greenville

Arizona

  • Maricopa Integrated Health Systems - Phoenix

Illinois

  • Northwestern Memorial Hospital - Chicago

Indiana

  • Indiana University Medical Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 5,011 participants
Start Date 2016-08
Est. Completion 2019-06

Sponsor

Sera Prognostics

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02787213

The ClinicalTrials.gov registry entry for NCT02787213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,011 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,494-participant average among 37 other Preterm Birth trials with a reported enrollment target (12% higher). The listed sponsor is Sera Prognostics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.

NCT02787213 reports 18 study locations spanning 13 distinct geographic areas - top geographies include California, Colorado, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02787213 about?

NCT02787213 is a clinical study titled "A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor". Prospective multicenter observational study to further develop and validate a preterm birth risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks gestation. A single maternal peripheral blood sample will be collected for analysis. Data related to potential risk factors...

What is the current status of trial NCT02787213?

This trial is currently completed. The enrollment target is 5,011 participants. The study started on 2016-08. Estimated completion is 2019-06.

What conditions does trial NCT02787213 study?

This clinical trial studies the following conditions: Preterm Birth.

Who is sponsoring clinical trial NCT02787213?

This trial is sponsored by Sera Prognostics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02787213 being conducted?

This trial has 18 study locations across Arizona, California, Colorado, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Preterm Birth

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.